EditorialKommentar
Trials and Tribulations — The Challenges of Clinical Trials in Children
NEJM Evidence · 2023
DOI: 10.1056/evide2300280 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM Evidence, 2023. Verfasst von Susan L Furth. Beteiligte Einrichtung: Research Institute, Children's Hospital of Philadelphia, Philadelphia. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Diabetes Mellitus, Type 2, Glucosides, Metformin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Benzhydryl CompoundsDiabetes Mellitus, Type 2GlucosidesMetforminAdolescentChildHumansBlood GlucoseDouble-Blind MethodDrug Therapy, CombinationHypoglycemic AgentsTreatment OutcomeUnited StatesAdamantaneDipeptides
Substanzen
Benzhydryl CompoundsBlood GlucoseGlucosidesHypoglycemic AgentsMetformindapagliflozinempagliflozinsaxagliptinAdamantaneDipeptides
Autor:innen und Institutionen
- Research Institute, Children's Hospital of Philadelphia, Philadelphia.
- Division of Nephrology, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Zitieren
APA
Furth, S. L. (2023). Trials and Tribulations — The Challenges of Clinical Trials in Children. NEJM Evidence. https://doi.org/10.1056/evide2300280
Vancouver
Furth SL. Trials and Tribulations — The Challenges of Clinical Trials in Children. NEJM Evidence. 2023. doi:10.1056/evide2300280
BibTeX
@article{Furth2023,
author = {Furth, Susan L},
title = {Trials and Tribulations — The Challenges of Clinical Trials in Children},
journal = {NEJM Evidence},
year = {2023},
doi = {10.1056/evide2300280}
}
EUVIMED